Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments
Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments
SciSparc Ltd. (NASDAQ:SPRC) announced on Friday that it has enrolled the first patient in the company's clinical trial assessing the efficacy and safety of its cannabidiol (CBD) – based drug for the treatment of children with autism spectrum disorder.
ScisPARC Ltd.（納斯達克股票代碼：SPRC）週五宣佈，該公司已招募了第一位患者參加該公司的臨床試驗，該試驗評估了其大麻二酚（CBD）爲基礎的治療自閉症譜系障礙兒童的藥物的療效和安全性。
SCI-210 is a combination of CBD and CannAmide – the company's Palmitoylethanolamide – which is designed to alleviate ASD symptoms.
SCI-210 是 CBD 和 CannaMide（該公司的棕櫚酰乙醇胺）的組合，旨在緩解自閉症症狀。
Why It Matters
爲什麼重要
"The enrollment of our first patient means that we are moving towards a new frontier in the treatment of ASD," said Oz Adler, the company's CEO. "We are pleased to enroll the first patient in the trial, which will further our understanding of the potential role of SCI-210 in the treatment of ASD symptoms."
該公司首席執行官奧茲·阿德勒說：“我們的第一位患者入組意味着我們正在朝着自閉症障礙治療的新領域邁進。”“我們很高興招收第一位患者參加該試驗，這將加深我們對 SCI-210 在治療自閉症症狀中的潛在作用的理解。”
The Israel-based SciSparc said it will enroll 60 participants between the ages of 5 and 18, for 20 weeks. The goal of the trial, which is designed in consultation with the National Autism Research Center, is to examine how SCI-210 therapy compares to standard CBD treatment in managing symptoms of ASD.
總部位於以色列的ScisPARC表示，它將招收60名年齡在5至18歲之間的參與者，爲期20周。該試驗是與國家自閉症研究中心協商後設計的，目標是研究 SCI-210 療法在控制自閉症症狀方面與標準 CBD 治療相比如何。
The company signed an agreement with Israel's manufacturer and distributor of cannabis-based products, Tikun Olam Cannbit Pharmaceuticals Ltd. (OTC:TKUNF), to supply its CBD-rich oil from Cannbit strains to be used as part of SCI-210 treatment, last year.
去年，該公司與以色列大麻類產品的製造商和分銷商Tikun Olam Cannbit Pharmicals Ltd.（場外交易代碼：TKUNF）簽署了一項協議，供應來自Cannbit菌株的富含CBD的油，用作 SCI-210 治療的一部分。
See also: Cannabis & Children Autism: New Study Claims CBDA Can Help With Behavioral Issues In Kids With ASD
另見：大麻與兒童自閉症：新研究稱CBDA可以幫助解決自閉症兒童的行爲問題
What's Next
下一步是什麼
SciSparc intends to sell SCI-210 in Israel initially with an international drug roll-out subject to obtaining the requisite regulatory approvals.
ScisPARC最初打算在以色列銷售 SCI-210，並在國際上推出藥物，但須獲得必要的監管部門批准。
In the meantime, it was a busy week for the Tel Aviv-based company.
同時，對於這家總部位於特拉維夫的公司來說，這是忙碌的一週。
SpiSparc's Recent Milestones
SpisPARC 的最新里程碑
On Wednesday, SpiSparc said in a press release that it had received patent approval for its proprietary combination of opioids and n-acylethanolamines for pain treatment. The patent has been granted by the government agency Canadian Intellectual Property Office.
週三，SpisPARC在一份新聞稿中表示，其用於疼痛治療的阿片類藥物和n-酰乙醇胺的專有組合已獲得專利批准。該專利已由政府機構加拿大知識產權局授予。
The company also announced that the process of granting and validating its core technology patent is now completed in 15 European countries. This patent covers combinations of cannabinoids and n-acylethanolamines and aligns with the company's proprietary technology designed to enhance the safety of cannabinoids by using low dosages of active components while maintaining their therapeutic benefits.
該公司還宣佈，其核心技術專利的授予和驗證程序現已在15個歐洲國家完成。該專利涵蓋了大麻素和正酰乙醇胺的組合，符合該公司的專有技術，該技術旨在通過使用低劑量的活性成分來增強大麻素的安全性，同時保持其治療功效。
Now read: Cannabis Can Be A Game-Changer For Improving The Lives Of Autistic Adults
立即閱讀：大麻可以改變遊戲規則，改善自閉症成年人的生活
SPRC Price Action
SPRC 價格走勢
SciSparc's shares traded 3.8889% lower at $3.46 per share at the time of writing on Friday morning.
在週五上午撰寫本文時，ScisPARC的股價下跌3.8889％，至每股3.46美元。
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
本辛加大麻資本會議將於2024年4月16日和17日在佛羅里達州好萊塢的新地點重返佛羅里達州。在外交官海灘度假村舉行的爲期兩天的活動將爲大小企業家提供交流、學習和成長的機會。這次會議以其引領潮流的能力和對大麻未來的影響而聞名，記住你的日曆——這是大麻界年度必去的活動。
Get your tickets now on bzcannabis.com – Prices will increase very soon!
立即購買門票 bzcannabis.com — 價格很快就會上漲！
譯文內容由第三人軟體翻譯。